drugset / Trial / NCT07061847

Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines

NCT07061847

Phase 2 Recruiting 40 enrolled Northwell Health
NaSingle-groupOpen-labelTreatment

Summary

The main purpose of this study is to evaluate the effectiveness of a new treatment in improving chronic migraine symptoms. This treatment involves a targeted lidocaine infusion into blood vessels in the skull to numb pain receptors, potentially leading to improvements in chronic migraine intensity, frequency, and duration.

Timeline

Start
2025-03-10
Primary completion
2027-03-10
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1 % Other

Indications